Veracyte Inc [VCYT] stock prices are up 1.15% to $43.8 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VCYT shares have gain 3.18% over the last week, with a monthly amount glided 2.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Canaccord Genuity started tracking the stock with Hold rating on October 20, 2025, and set its price target to $40. On March 20, 2025, Craig Hallum initiated with a Buy rating and assigned a price target of $45 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $37 on December 05, 2024. Wolfe Research initiated its recommendation with an Outperform and recommended $50 as its price target on November 15, 2024. UBS started tracking with a Buy rating for this stock on October 16, 2024, and assigned it a price target of $43. In a note dated October 10, 2024, Guggenheim initiated a Buy rating and provided a target price of $40 on this stock.
The stock price of Veracyte Inc [VCYT] has been fluctuating between $22.61 and $50.71 over the past year. Currently, Wall Street analysts expect the stock to reach $47.25 within the next 12 months. Veracyte Inc [NASDAQ: VCYT] shares were valued at $43.8 at the most recent close of the market. An investor can expect a potential return of 7.88% based on the average VCYT price forecast.
Analyzing the VCYT fundamentals
The Veracyte Inc [NASDAQ:VCYT] reported sales of 495.14M for trailing twelve months, representing a surge of 13.82%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Veracyte Inc [NASDAQ:VCYT]’s Current Ratio is 6.23. In addition, the Quick Ratio stands at 5.94 and the Cash Ratio stands at 4.37. Considering the valuation of this stock, the price to sales ratio is 6.99, the price to book ratio is 2.75 and price to earnings (TTM) ratio is 115.35.
Transactions by insiders
Recent insider trading involved McGuire Annie, SVP, General Counsel, that happened on Dec 16 ’25 when 10739.0 shares were sold. Officer, ANN MCGUIRE completed a deal on Dec 16 ’25 to buy 10739.0 shares. Meanwhile, Director EASTHAM KARIN sold 20000.0 shares on Dec 05 ’25.
